Ibandronate Sodium Tablets

The contract SPE2D2-26-D-0015 is a firm-fixed-price award for the procurement of Ibandronate Sodium Tablets, 150mg in 3-count packaging, under a five-year period consisting of a base year and four option years. The contractor, Golden State Medical Supply, Inc., will deliver the product to DLA and VA Pharmaceutical Prime Vendors, with manufacturing and packaging handled by Apotex Corporation in Etobicoke, Ontario, Canada. Delivery is FOB Destination, meaning the contractor retains risk of loss until delivery is completed. The base year quantity is 27,881 packs at $16.94 per pack, totaling $472,304.14, with option years maintaining the same volume but with slight price increases: $16.97 per pack starting in Year 2. The total estimated contract value is approximately $2.36 million. The contract is a total small business set-aside under NAICS code 325412, eligible for participation by small businesses, HubZone firms, service-disabled veteran-owned small businesses, women-owned small businesses, economically disadvantaged women-owned small businesses, and 8(a) participants. The contract incorporates numerous FAR and DFARS clauses governing ethical conduct, labor standards, supply chain integrity, and compliance with federal regulations. Key clauses include those addressing trafficking in persons, whistleblower protections, employee eligibility verification, small business subcontracting plans, Buy American provisions, and prohibitions on contracting with entities linked to Kaspersky Lab, ByteDance, or Russian fossil fuel operations. The contractor must also comply with requirements for unique item identification, record retention, and accelerated payments to small business subs. Packaging and marking specifications are not detailed in the provided material, though DFARS 252.211-7003 for Item Unique Identification is referenced. Inspection occurs at the delivery point, and acceptance is presumed upon delivery to designated prime vendor locations. Government oversight is managed by DLA Troop Support in Philadelphia, with primary point of contact Christopher Newman and secondary contact Jason Wray. The contract includes no explicit COR/COTR designation, nor does it specify evaluation factors, security clearances, or key personnel requirements. Invoicing is directed to the designated prime vendor address, with electronic systems like WAWF likely anticipated but not explicitly mandated.